Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
5/31/2025
CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies
5/31/2025
Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...
5/29/2025
AusperBio Secures $50M in Series B+ Financing
5/29/2025
Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million
5/28/2025
Vigene and Merz Expand Strategic Partnership Across Greater China
5/28/2025
Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...
5/27/2025
Pharma Distribution Market Steady with 5.6% Growth in the 14th FYP
5/27/2025
Salubris Invests CNY 550M in Next-Gen Hypertension siRNA Therapy with ...
5/27/2025
PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies
5/27/2025
Sinotau Files for HK IPO to Advance Radiopharma Innovations
5/27/2025
XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...
5/23/2025
Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...
5/22/2025
China Approves Hengrui's Camrelizumab-Famitinib Combo
5/22/2025
Hengrui Pharma Raises $1.27B in Hong Kong Listing
5/21/2025
China's Drugstores Decline Amid Boom in Online Healthcare
5/21/2025
China Surges Ahead in Oncology Licensing, GlobalData Reports
5/21/2025
CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy
5/21/2025
CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...
5/20/2025
CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102
5/20/2025
SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration
5/20/2025
WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
5/20/2025
JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
5/20/2025
Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
5/20/2025
Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
5/16/2025
WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
5/16/2025
Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery
5/16/2025
US Push to Decouple from China May Spike Drug Costs, Experts Warn
5/16/2025
CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
5/16/2025
ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...
5/15/2025
Hengrui Aims to Raise $1.27B in Hong Kong IPO
Page:
1
/
22
Total number of articles:
648
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit